Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome
2017
Age does not adversely influence outcomes among patients older than 60 years who undergo allogeneic hematopoietic stem cell transplant for AML and myelodysplastic syndrome
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
46
References
15
Citations
NaN
KQI